ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

RGBPD Regen Biopharma Inc (PK)

2.015
0.00 (0.00%)
Jun 17 2024 - Closed
Delayed by 15 minutes

Regen Biopharma (PK) Financial Summary

The current RGBPD market cap is 6.81M. The company's latest EPS is USD 0.3422 and P/E is 5.87.

Year End September 29 2023 20222023
USD ($)USD ($)
Total Revenue 236k237k
Operating Income -339k-686k
Net Income 2.44M1.16M
Year End September 29 2023 20222023
USD ($)USD ($)
Total Assets 559k354k
Total Liabilities 8.6M5.46M
Total Equity -8.04M-5.1M

Cash Flow

Year End September 29 2023 20222023
USD ($)USD ($)
Operating -607k-174k
Investing 25k N/A
Financing -94k244k
Market Cap 6.81M
Price to Earnings Ratio 5.87
Price to Sales Ratio 28.67
Price to Cash Ratio 56.15
Price to Book Ratio -1.33
Dividend Yield -

Share Statistics

Shares Outstanding 3.38M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Regen Biopharma Inc (PK)
Address 50 west liberty street, suite 880
reno, nevada 89501
Website https://www.regenbiopharmainc.com
Industry pharmaceutical preparations (2834)